Debug Stats | ### Total Build Time: 439 ms 39.277 KB CONCEPT_NAME gt=4 ms Completed: 4 ms rowSize= 320 bytesCONCEPT_SOLR_HIT_STATS gt=0 Completed: 0 ms rowSize= 14 bytesCONCEPT_DEFINITION gt=0 Completed: 0 ms rowSize= 582 bytes- Skipping details on:
CONCEPT_SYNONYM gt=NONE 0 Completed: 0 ms rowSize= 0 bytes - Skipping details on:
CONCEPT_TEXT gt=NONE 0 Completed: 0 ms rowSize= 0 bytes CONCEPT_SEMANTIC_TYPE gt=0 Completed: 0 ms rowSize= 232 bytes- Skipping details on:
CONCEPT_NAMESPACE gt=NONE 0 Completed: 0 ms rowSize= 0 bytes CONCEPT_PARENTS gt=4 ms Completed: 4 ms rowSize= 563 bytesCONCEPT_CHILDREN gt=0 Completed: 0 ms rowSize= 8 bytesCONCEPT_ANCESTRAL_ROOTS gt=2 ms Completed: 2 ms rowSize= 1.526 KBCONCEPT_RELATIONSHIPS gt=411 ms Completed: 411 ms rowSize= 14.128 KBCONCEPT_GENES gt=15 ms Completed: 15 ms rowSize= 20.785 KBCONCEPT_XREFS gt=3 ms Completed: 3 ms rowSize= 1.146 KBCONCEPT_ANCILLARY gt=0 Completed: 0 ms rowSize= 14 bytes- Reload Stats
|
Genes (20)
Species: human : 20 | |
Human | SLC26A7 | 115111 | solute carrier family 26 (anion exchanger), member 7 | The trafficking to the cell surface suggests novel functional upregulation of SLC26A7 in states that are associated with hypokalemia or increased medullary tonicity | Human | KCNE3 | 10008 | potassium voltage-gated channel, Isk-related family, member 3 | Hypokalemia occurs during paralytic attacks Attacks precipitated by hypokalemia, administration of glucose or insulin, heavy carbohydrate consumption, stress, fatigue, rest after exercise | Human | AIP | 9049 | aryl hydrocarbon receptor interacting protein | | Human | BSND | 7809 | Bartter syndrome, infantile, with sensorineural deafness (Barttin) | | Human | SLC12A3 | 6559 | solute carrier family 12 (sodium/chloride transporter), member 3 | | Human | SLC12A1 | 6557 | solute carrier family 12 (sodium/potassium/chloride transporter), member 1 | | Human | SLC2A2 | 6514 | solute carrier family 2 (facilitated glucose transporter), member 2 | | Human | SCNN1G | 6340 | sodium channel, non-voltage-gated 1, gamma subunit | | Human | SCNN1B | 6338 | sodium channel, non-voltage-gated 1, beta subunit | | Human | SCN4A | 6329 | sodium channel, voltage-gated, type IV, alpha subunit | Attacks precipitated by hypokalemia, administration of glucose or insulin, heavy carbohydrate consumption, stress, fatigue, rest after exercise Hypokalemia occurs during paralytic attacks | Human | PTEN | 5728 | phosphatase and tensin homolog | | Human | SMAD4 | 4089 | SMAD family member 4 | | Human | KCNJ2 | 3759 | potassium inwardly-rectifying channel, subfamily J, member 2 | Periodic paralysis, usually hypokalemic Hypokalemia during periodic paralysis (most patients) | Human | KCNJ1 | 3758 | potassium inwardly-rectifying channel, subfamily J, member 1 | | Human | CYP11B1 | 1584 | cytochrome P450, family 11, subfamily B, polypeptide 1 | | Human | CLCNKB | 1188 | chloride channel, voltage-sensitive Kb | | Human | CLCNKA | 1187 | chloride channel, voltage-sensitive Ka | | Human | CACNA1S | 779 | calcium channel, voltage-dependent, L type, alpha 1S subunit | Hypokalemia occurs during paralytic attacks Attacks precipitated by hypokalemia, administration of glucose or insulin, heavy carbohydrate consumption, stress, fatigue, rest after exercise | Human | BMPR1A | 657 | bone morphogenetic protein receptor, type IA | | Human | ADRB2 | 154 | adrenoceptor beta 2, surface | In patients carrying the Arg-16 genotype the development of hypokalemia by s.c. terbutaline is attenuated after pre-treatment with inhaled terbutaline, be it on the basis of higher baseline values |
|